In a minority (<10%) of patients, the need for insulin therapy continues after delivery, and in these cases detection of anti-glutamic-acid-decarboxylase- (GAD-) 65 antibodies (GAD65-Ab) is common, and so GDM is considered the onset of type 1 diabetes [4–6]. Here, GAD2 is linked to type 1 diabetes mellitus.